KIT and gastrointestinal stromal tumor: A number of studies with low molecular-weight compounds have shown correlations between their c-KIT/c-KIT1 G4 binding and inhibition of c-KIT expression (39–44) and it has been suggested that quadruplex targeting may be a novel approach to the therapy of GIST.